Here are four points:
1. A rise in degenerative disease cases will drive the market’s growth.
2. Lateral lumbar interbody fusion surgery complications will present an obstacle for the market’s growth.
3. The market will see regulatory changes in device classification.
4. DePuy Synthes, Medtronic, NuVasive and Stryker lead the market.
More articles on devices:
Australian researcher creates new spinal fusion device: 6 insights
LDR Holding partners with Poly-Shape for spinal implant manufacturing: 5 points
Global hip, knee orthopedic surgical robots market to reach $5B by 2022 — 4 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
